CA2568823C - Comprimes de progesterone a administration vaginale et methode de preparation - Google Patents

Comprimes de progesterone a administration vaginale et methode de preparation Download PDF

Info

Publication number
CA2568823C
CA2568823C CA2568823A CA2568823A CA2568823C CA 2568823 C CA2568823 C CA 2568823C CA 2568823 A CA2568823 A CA 2568823A CA 2568823 A CA2568823 A CA 2568823A CA 2568823 C CA2568823 C CA 2568823C
Authority
CA
Canada
Prior art keywords
progesterone
tablet
effervescent
amount
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2568823A
Other languages
English (en)
Other versions
CA2568823A1 (fr
Inventor
Vladimir Ivanov Yankov
Azariah Jossifoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/408,614 external-priority patent/US20060188571A1/en
Application filed by Ferring BV filed Critical Ferring BV
Publication of CA2568823A1 publication Critical patent/CA2568823A1/fr
Application granted granted Critical
Publication of CA2568823C publication Critical patent/CA2568823C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Le présente invention décrit à une méthode de fabrication de comprimé pour l'administration vaginale de progestérone aux fins de traitement systémique. L'invention décrit également des comprimés fabriqués selon cette méthode, de même que les méthodes d'administration vaginale desdits comprimés trois fois par jour à des patientes de sexe féminin traitées contre l'infertilité ou des troubles liés à la grossesse dans le cadre d'un programme de FIV. Enfin, sont aussi décrites les méthodes d'administration de comprimés contenant 100 mg de progestérone naturelle au moins trois fois par jour à des patientes de sexe féminin nécessitant un soutien de la phase lutéale (c.-à-d. patientes âgées, souffrant d'embonpoint ou d'obésité ou inscrites à un programme de dons d'ovocytes).
CA2568823A 2006-04-20 2006-11-24 Comprimes de progesterone a administration vaginale et methode de preparation Expired - Fee Related CA2568823C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/408,614 US20060188571A1 (en) 1998-11-18 2006-04-20 Vaginally administrable progesterone containing tablets and method for preparing the same
US11/408,614 2006-04-20

Publications (2)

Publication Number Publication Date
CA2568823A1 CA2568823A1 (fr) 2007-10-20
CA2568823C true CA2568823C (fr) 2012-02-07

Family

ID=38606770

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2568823A Expired - Fee Related CA2568823C (fr) 2006-04-20 2006-11-24 Comprimes de progesterone a administration vaginale et methode de preparation

Country Status (1)

Country Link
CA (1) CA2568823C (fr)

Also Published As

Publication number Publication date
CA2568823A1 (fr) 2007-10-20

Similar Documents

Publication Publication Date Title
AU2022283615B2 (en) Orodispersible dosage unit containing an estetrol component
RU2402331C2 (ru) Дроспиренон для гормональной заместительной терапии
RU2330667C2 (ru) Прогестинотерапия с регулируемым кровотечением
US7320800B2 (en) Vaginally administrable progesterone-containing tablets and method for preparing same
US11957694B2 (en) Orodispersible dosage unit containing an estetrol component
Levy et al. Pharmacokinetics of the progesterone-containing vaginal tablet and its use in assisted reproduction
MXPA04006057A (es) Productos farmaceuticos orales que contienen 3-alcanoato inferior de 17-beta-estradiol, metodo para administrar los mismos y proceso de preparacion.
TW200904452A (en) New drospirenone/17β-estradiol regimen, pharmaceutical combination, product and kit for performing this regimen
CA2568823C (fr) Comprimes de progesterone a administration vaginale et methode de preparation
US20070178139A1 (en) Vaginally administratable progesterone-containing tablets and method for preparing same
JP2001523639A (ja) プロゲストゲン−抗プロゲストゲンレジメン
US20230080934A1 (en) Orodispersible formulations
US20240115490A1 (en) Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof
TWI239249B (en) Vaginally administrable progesterone-containing tablets and method for preparing same
US20220313705A1 (en) Cyproterone acetate compositions and uses thereof
Sathapathy Development and Evaluation of Dienogest Vaginal Tablet for Treatment of Endometriosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201124